Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel form of vitamin D shown to grow bone

01.10.2002


A novel form of vitamin D has been shown to grow bone in the lab and in experimental animals, a result that holds promise for the estimated 44 million Americans, mostly post-menopausal women, who suffer from or are at risk for the bone-wasting disease osteoporosis.



The research, conducted by a team of scientists led by biochemist Hector F. DeLuca at the University of Wisconsin-Madison, was reported this week (Sept. 30) in the Proceedings of the National Academy of Sciences (PNAS), a leading scientific journal.

"We’ve got a compound that is very selective for bone," says DeLuca. "It is very effective in animals," increasing bone density significantly in rats with a condition that mimics human osteoporosis, and can be used in the lab to grow bone in culture.


The research, conducted by DeLuca, Nirupama K. Shevde, Lori A. Plum, Margaret Claggett-Dame, Hironori Yamamoto and J. Wesley Pike, describes the effects of a potent Vitamin D analog known in scientific shorthand as 2MD. Its synthesis by the Wisconsin group, and studies of its effects in the lab and in animals, suggests the potential for developing a class of drugs that could effectively reverse bone loss in humans suffering from osteoporosis, a disease characterized by diminished bone density and, ultimately, brittle, fracture-prone bones.

"From where I sit, this is the most promising vitamin D compound I’ve seen," says DeLuca, an international authority on vitamin D and its chemistry.

But he stressed that while the new compound posts astonishing results when used in experimental animals, it has yet to be tested in humans and it will likely be several years at best before a drug reaches the market.

"There’s nothing like it on the market now. We think it could become a major actor, but we haven’t done any experiments in people," he says.

The compound could become an important alternative to hormone replacement therapy, one of whose benefits was prevention of bone loss in post-menopausal women. Because of new evidence of an increased risk of cancer, hormone replacement therapy has recently been called into question.

The vitamin D analog developed by the Wisconsin team was tested in rats that had their ovaries removed to mimic menopause and the bone wasting associated with osteoporosis. Rats given the new vitamin D analog exhibited a 9 percent increase in total body bone mass. Importantly, vertebrae in the treated rats exhibited a 25 percent increase in bone mass. Frequently, osteoporosis patients exhibit a stooped posture as the bones in the spinal column tend to be among the most affected by osteoporosis.

The compound also added bone mass to the long bones in the limbs of animals used in the study.

According to DeLuca, the 2MD compound is also the first vitamin D analog shown to increase bone mass, and that exhibits no apparent toxicity or side effects.

2MD acts at very low concentrations and appears to work by promoting the growth of osteoblasts, the cells responsible for making bone. Another form of vitamin D is now used to treat osteoporosis, but its bone-building action is limited.

"Our results suggest that 2MD exhibits at very low concentrations a marked and unexpected activity in stimulating the synthesis of new bone," the Wisconsin team wrote in their PNAS report. "This activity is at best only weakly observed with (the other active form of vitamin D) and then only at very high concentrations."

It is possible, the authors suggest, that 2MD possesses a "unique capacity to induce genes capable of orchestrating the process leading to the formation of bone nodules."


Terry Devitt (608) 262-8282, trdevitt@facstaff.wisc.edu;
Emily Carlson (608) 262-9772, emilycarlson@facstaff

Hector F. DeLuca | EurekAlert!
Further information:
http://www.news.wisc.edu/newsphotos/deluca.html

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>